SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-076939
Filing Date
2017-03-09
Accepted
2017-03-09 16:29:01
Documents
76
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d342545d10k.htm 10-K 1092688
2 EX-23.1 d342545dex231.htm EX-23.1 1927
3 EX-31.1 d342545dex311.htm EX-31.1 9041
4 EX-31.2 d342545dex312.htm EX-31.2 9111
5 EX-32.1 d342545dex321.htm EX-32.1 4550
6 EX-32.2 d342545dex322.htm EX-32.2 4447
13 GRAPHIC g342545g05o67.jpg GRAPHIC 96859
  Complete submission text file 0001193125-17-076939.txt   5161753

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aqxp-20161231.xml EX-101.INS 848631
8 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20161231.xsd EX-101.SCH 54123
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20161231_cal.xml EX-101.CAL 80352
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20161231_def.xml EX-101.DEF 171719
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20161231_lab.xml EX-101.LAB 468802
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20161231_pre.xml EX-101.PRE 326254
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36327 | Film No.: 17678867
SIC: 2834 Pharmaceutical Preparations